Related Experiment Video
Updated: Jun 10, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in
Bangqiong Wang1, Qifu Li, Yuanjuan Jiang
1Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No 1 Youyi Street, Chongqing 400016, China.
Objective:
To compare association of complement C3 (C3) and high sensitive C-reactive protein (hs-CRP) with insulin resistance.
Subjects:
A total of 587 non-diabetic Chinese aged 20-80 years were recruited.
Methods:
Complement C3 and hs-CRP were measured by the rate nephelometry method and the particle enhanced immunoturbidimetric method, respectively, and their relationship to insulin resistance was assessed. Insulin resistance was defined as the upper quartile of HOMA2-IR.
Results:
Complement C3 and hs-CRP were significantly higher in subjects with insulin resistance than those without. Complement C3 was the second strongest determinant of insulin in the study (β = 0.34, P < 0.001). By regression analysis, C3 was significantly associated with insulin resistance (OR = 3.78, P < 0.05), independent of waist circumference and other metabolic risk factors; however, hs-CRP was not. Receiver operating characteristic curve analysis indicated the best model predicting insulin resistance was one that included C3 and waist circumference (AUC = 0.741, P < 0.05).
Conclusion:
Compared to hs-CRP, serum C3 might be a better inflammatory marker of insulin resistance in the non-diabetic Chinese population.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology